Anixa Biosciences, Inc. (ANIX)
NASDAQ · Manufacturing · Pharmaceutical preparations
ANIX price, last 12 months
Key stats
- Previous close
- $2.78
- Open
- $2.85
- Day range
- $2.69 – $2.87
- 52-week range
- $2.32 – $5.46
- Volume
- 360.9K
- Avg volume (20 days)
- 380.2K
- Market cap
- $96.6M
Performance
Technicals and fundamentals
About Anixa Biosciences, Inc.
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $96.6M